NICI Quick Take

Founded in 2017, Starling is a Toronto-based producer of high quality medical and recreational cannabis that operates out of California.  It operates primarily through its subsidiary Kase Manufacturing, Inc., which is an approved cannabis extraction and manufacturing lab in California with the capacity to extract 35,360 kilograms annually. Jayden’s Juice is manufactured at this facility, which is Starling’s flagship health-conscious brand that originated from a father trying to help his epileptic son.

In December 2019, Starling entered into a brand licensing agreement with an unknown but experienced cosmetics industry company for its Cerius line of topical CBD products. This cosmetics company will distribute Starling’s Cerius line in the United Kingdom and the European Union. As part of the agreement, Starling will sell the cosmetic company’s THC topical products throughout dispensaries in California starting Q1 2020.

in addition, Starling is currently negotiating a distribution agreement for its Jayden’s Juice line of products that could potentially be sold in hundreds of California’s dispensaries.

The deadline for the business combination between Trius Investments and Starling Brands was delayed and pushed back until March 31, 2020, resulting in a later than expected IPO. 

IPO Details

Valuation N/A
Total Raised $20.0M
NICI Subsector N/A
Website manifest7.com